Evidence map›Paper›PMID 26365120›Full record

ArticleJournal of Zhejiang University. Science. B2015

Protective effect of L-carnitine in cyclophosphamide-induced germ cell apoptosis.

Bin Zhu, Yan-fei Zheng, Yue-ying Zhang, Yun-song Cao, Lei Zhang, Xin-gang Li, Teng Liu, Zhao-zhu Jiao, Qi Wang, Zhi-gang Zhao

Open access · bronzeAbstract read
In one paragraph

Article in Journal of Zhejiang University. Science. B, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 36 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Cyclophosphamide-induced testicular toxicity ameliorate byInternational journal of reproductive biomedicine · 2018
    Article
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 2 countries.

Bin ZhuDepartment of Pharmacy, Beijing Tiantan Hospital, Capital Medical University, Beijing 100050, China.
Yan-fei ZhengSchool of Basic Medicine, Beijing University of Chinese Medicine, Beijing 100029, China.
Yue-ying ZhangDepartment of Chinese Medicine, Beijing Hepingli Hospital, Beijing 100013, China.
Yun-song CaoDepartment of Nephrology, Dongfang Hospital, the Second Clinical Medical College of Beijing University of Chinese Medicine, Beijing 100078, China.
Lei ZhangDepartment of Pharmacy, Beijing Shijitan Hospital, Beijing 100038, China.
Xin-gang LiDepartment of Pharmacy, Beijing Tiantan Hospital, Capital Medical University, Beijing 100050, China.
Teng LiuDepartment of Pharmacy, Beijing Tiantan Hospital, Capital Medical University, Beijing 100050, China.
Zhao-zhu JiaoSchool of Basic Medicine, Beijing University of Chinese Medicine, Beijing 100029, China.
Qi WangSchool of Basic Medicine, Beijing University of Chinese Medicine, Beijing 100029, China.
Zhi-gang ZhaoDepartment of Pharmacy, Beijing Tiantan Hospital, Capital Medical University, Beijing 100050, China.
Beijing University of Chinese Medicine · CNCapital University · USBeijing Anding Hospital · CNBeijing Shijitan Hospital · CNBeijing Tian Tan Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cyclophosphamide (CP) is a widely used anti-cancer agent; however, it can also induce serious male infertility. There are currently no effective drugs to alleviate this side-effect. L-Carnitine has been used to treat male infertility, but whether it can be used to protect against CP-induced male infertility is still unclear. This study aims to explore the effect and mechanism of L-carnitine in male infertility induced by CP. CP was used to establish an animal model. After three weeks of treatment, rats were sacrificed and testis and serum were harvested for further evaluation. Testosterone and estrogen levels were measured by enzyme-linked immunosorbent assay (ELISA). Testicular injury was examined by hematoxylin and eosin (H & E) staining, and germ-cell apoptosis was evaluated by terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL). The expression of LC3 and Beclin-1 was examined by immunohistochemistry, Western blot, and real-time polymerase chain reaction (PCR), respectively. Compared with the CP group, L-carnitine significantly increases sperm motility, viability, and testosterone level (P<0.05). Western blot and real-time PCR results showed that L-carnitine treatment can significantly up-regulate the LC3-II and Beclin-1 expression in the CP+L-carnitine group when compared with the control group (P<0.05). In addition, TUNEL-positive cells were also more numerous in the CP group; however, L-carnitine can effectively retard cell apoptosis in the CP+L-carnitine group. In conclusion, L-carnitine contributes to the inhibition of cell apoptosis and the modulation of autophagy in protecting CP-induced testicular injury. These results suggest the applicability of L-carnitine in the treatment of male infertility.

Indexed as

AnimalsApoptosisCarnitineCells, CulturedCyclophosphamideCytoprotectionDose-Response Relationship, DrugDrug InteractionsGerm CellsMaleRatsRats, WistarSpermatozoaSperm MotilityTreatment OutcomeCarnitineCyclophosphamideBeclin-1CyclophosphamideInfertilityLC3L-Carnitine

Identifiers

PMID26365120
PMCPMC4569686
OpenAlexW1636780307

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.